vs
Amerant Bancorp Inc.（AMTB）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Amerant Bancorp Inc.的1.8倍（$197.9M vs $112.2M），REPLIGEN CORP净利率更高（6.7% vs 3.0%，领先3.7%），REPLIGEN CORP同比增速更快（13.6% vs 2.9%），Amerant Bancorp Inc.自由现金流更多（$129.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 10.1%）
阿梅兰特银行是一家注册于美国佛罗里达州的本土银行，总部坐落于佛罗里达州科勒尔盖布尔斯。目前该行在佛罗里达州共设有19家实体分行，通过自有运营及合作网络可提供超过5.5万台ATM的取款服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AMTB vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$112.2M
营收增速更快
RGEN
高出10.8%
2.9%
净利率更高
RGEN
高出3.7%
3.0%
自由现金流更多
AMTB
多$111.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.2M | $197.9M |
| 净利润 | $2.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 1.7% | 9.0% |
| 净利率 | 3.0% | 6.7% |
| 营收同比 | 2.9% | 13.6% |
| 净利润同比 | -84.0% | 143.9% |
| 每股收益（稀释后） | $0.08 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMTBRGEN
| Q4 25 | $112.2M | $197.9M | ||
| Q3 25 | $111.4M | $188.8M | ||
| Q2 25 | $110.3M | $182.4M | ||
| Q1 25 | $105.4M | $169.2M | ||
| Q4 24 | $87.6M | $174.1M | ||
| Q3 24 | $33.3M | $154.9M | ||
| Q2 24 | $98.8M | $154.1M | ||
| Q1 24 | $92.5M | $151.3M |
净利润AMTBRGEN
| Q4 25 | $2.7M | $13.3M | ||
| Q3 25 | $14.8M | $14.9M | ||
| Q2 25 | $23.0M | $14.9M | ||
| Q1 25 | $12.0M | $5.8M | ||
| Q4 24 | $16.9M | $-30.3M | ||
| Q3 24 | $-48.2M | $-654.0K | ||
| Q2 24 | $5.0M | $3.3M | ||
| Q1 24 | $10.6M | $2.1M |
毛利率AMTBRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率AMTBRGEN
| Q4 25 | 1.7% | 9.0% | ||
| Q3 25 | 17.1% | 8.9% | ||
| Q2 25 | 27.0% | 7.6% | ||
| Q1 25 | 14.6% | 3.9% | ||
| Q4 24 | 20.6% | -17.7% | ||
| Q3 24 | -185.8% | -5.1% | ||
| Q2 24 | 6.4% | 1.0% | ||
| Q1 24 | 14.6% | 1.3% |
净利率AMTBRGEN
| Q4 25 | 3.0% | 6.7% | ||
| Q3 25 | 13.2% | 7.9% | ||
| Q2 25 | 20.9% | 8.2% | ||
| Q1 25 | 11.3% | 3.4% | ||
| Q4 24 | 19.3% | -17.4% | ||
| Q3 24 | -144.6% | -0.4% | ||
| Q2 24 | 5.0% | 2.2% | ||
| Q1 24 | 11.4% | 1.4% |
每股收益（稀释后）AMTBRGEN
| Q4 25 | $0.08 | $0.24 | ||
| Q3 25 | $0.35 | $0.26 | ||
| Q2 25 | $0.55 | $0.26 | ||
| Q1 25 | $0.28 | $0.10 | ||
| Q4 24 | $0.53 | $-0.55 | ||
| Q3 24 | $-1.43 | $-0.01 | ||
| Q2 24 | $0.15 | $0.06 | ||
| Q1 24 | $0.31 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $938.8M | $2.1B |
| 总资产 | $9.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AMTBRGEN
| Q4 25 | — | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务AMTBRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMTBRGEN
| Q4 25 | $938.8M | $2.1B | ||
| Q3 25 | $944.9M | $2.1B | ||
| Q2 25 | $924.3M | $2.1B | ||
| Q1 25 | $906.3M | $2.0B | ||
| Q4 24 | $890.5M | $2.0B | ||
| Q3 24 | $902.9M | $2.0B | ||
| Q2 24 | $734.3M | $2.0B | ||
| Q1 24 | $738.1M | $2.0B |
总资产AMTBRGEN
| Q4 25 | $9.8B | $2.9B | ||
| Q3 25 | $10.4B | $2.9B | ||
| Q2 25 | $10.3B | $2.9B | ||
| Q1 25 | $10.2B | $2.9B | ||
| Q4 24 | $9.9B | $2.8B | ||
| Q3 24 | $10.4B | $2.8B | ||
| Q2 24 | $9.7B | $2.9B | ||
| Q1 24 | $9.8B | $2.8B |
负债/权益比AMTBRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $137.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $129.2M | $17.6M |
| 自由现金流率自由现金流/营收 | 115.2% | 8.9% |
| 资本支出强度资本支出/营收 | 6.9% | 4.1% |
| 现金转化率经营现金流/净利润 | 50.71× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $225.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流AMTBRGEN
| Q4 25 | $137.0M | $25.7M | ||
| Q3 25 | $22.7M | $48.1M | ||
| Q2 25 | $57.6M | $28.6M | ||
| Q1 25 | $20.2M | $15.0M | ||
| Q4 24 | $82.2M | $39.2M | ||
| Q3 24 | $4.2M | $49.3M | ||
| Q2 24 | $-2.3M | $42.2M | ||
| Q1 24 | $2.8M | $44.7M |
自由现金流AMTBRGEN
| Q4 25 | $129.2M | $17.6M | ||
| Q3 25 | $21.7M | $43.4M | ||
| Q2 25 | $56.3M | $21.5M | ||
| Q1 25 | $18.0M | $11.4M | ||
| Q4 24 | $74.8M | $33.6M | ||
| Q3 24 | $2.6M | $42.3M | ||
| Q2 24 | $-3.9M | $37.4M | ||
| Q1 24 | $-694.0K | $36.4M |
自由现金流率AMTBRGEN
| Q4 25 | 115.2% | 8.9% | ||
| Q3 25 | 19.5% | 23.0% | ||
| Q2 25 | 51.0% | 11.8% | ||
| Q1 25 | 17.1% | 6.8% | ||
| Q4 24 | 85.3% | 19.3% | ||
| Q3 24 | 7.8% | 27.3% | ||
| Q2 24 | -3.9% | 24.3% | ||
| Q1 24 | -0.8% | 24.0% |
资本支出强度AMTBRGEN
| Q4 25 | 6.9% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 1.2% | 3.9% | ||
| Q1 25 | 2.1% | 2.1% | ||
| Q4 24 | 8.4% | 3.2% | ||
| Q3 24 | 4.8% | 4.5% | ||
| Q2 24 | 1.5% | 3.1% | ||
| Q1 24 | 3.8% | 5.5% |
现金转化率AMTBRGEN
| Q4 25 | 50.71× | 1.93× | ||
| Q3 25 | 1.54× | 3.23× | ||
| Q2 25 | 2.50× | 1.92× | ||
| Q1 25 | 1.69× | 2.57× | ||
| Q4 24 | 4.87× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.47× | 12.70× | ||
| Q1 24 | 0.26× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMTB
| Other | $58.0M | 52% |
| Commercial Portfolio Segment | $25.7M | 23% |
| Commercial Real Estate Portfolio Segment | $17.3M | 15% |
| Consumer Portfolio Segment | $11.1M | 10% |
RGEN
暂无分部数据
